Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woolworths | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | $36.39B | 335.4x | -3.56 | $29.88 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Coles Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | $24.10B | 21.6x | 11.79 | $18.08 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.9% Upside | Upgrade to Pro+ | |
Endeavour Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | $7.84B | 18.6x | -4.68 | $4.28 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
Metcash | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | $3.40B | 12x | -3.49 | $3.10 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.1% Upside | Upgrade to Pro+ | |
Jatcorp | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | $37.47M | 16.7x | 0.12 | $0.45 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aumake | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | $16.88M | -1.5x | 0.25 | $0.006 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |